FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006588788> ?p ?o ?g. }

• W2006588788 endingPage "S175" @default.
• W2006588788 startingPage "S174" @default.
• W2006588788 abstract "Background/Purpose:Recently, 26 quality indicators (QI) categorized into 9 domains for childhood-onset systemic lupus erythematous (cSLE) have been developed based on international consensus and scientific evidence. QI are defined as minimum standards of medical care in support of optimal disease outcomes. The current level at which these QI are followed has not been well documented. Hence, the objective of this study is to assess the current quality of medical care received by patients with cSLE at tertiary pediatric rheumatology centers.Methods:Cross-sectional data pertaining to the QI were acquired via chart review and analyzed collectively in 290 cSLE patients followed at four tertiary pediatric rheumatology centers—two in the United States and two in Brazil.Results:Adherence to the QI differed by QI domain, ranging from 41 to 100%. The QI domain with the highest adherence 100% was Laboratory Testing at the time of diagnosis, and the lowest domain 41% was Medication Management. The recommended kidney biopsies for newly diagnosed lupus nephritis were done in only 67% of the patients and 85% of the patients received at least one of the recommended vaccinations (Table 1). Cardiovascular risks factors were discussed in 86% of cases when patient was 13 years or older. Adherence to the QI differences between countries and insurance status will be presented, supporting that the set of current QI are suitable for international use.Table 1. Adherence to QI by DomainQuality Indicators by DomainResultsLab testing at diagnosis & screening Obtained diagnostic/confirmatory labs within first two visits100%Obtained lab surveillance of CBC, renal, LFT every 12 months85%General prevention Prescribed influenza and/or encapsulated organisms vaccination, unless contraindicated85%Discussed and documented education on sun avoidance at least once in the medical record (e.g., wearing protective clothing, applying sunscreens whenever outdoors, and avoiding sunbathing)89%Discussed transition plan to appropriate adult healthcare providers with patient age ≥14 years.78%Lupus nephritis (LN) and hypertension management Kidney biopsy discussed/ordered/performed if developed proteinuria >500 mg/day, or worsening GFR, or urinary sediment60%Evaluated by a nephrologist in the last year of care for lupus nephritis (LN) and of hypertension65%Evaluated by rheumatologist every 3 months in last year if a patient has known LN regardless of disease activity.96%Received kidney biopsy when diagnosed with LN67%Class III/IV, treated with immunosuppressive + glucocorticoids within 1 month92%Angiotensin receptor blocker (ARB) or, Angiotensin–converting enzyme (ACE) inhibitor were prescribed if ongoing proteinuria >500 mg/day or worsening GFR in last year of care.96%Check assessments (Kidney function, urine sediment, and proteinuria) every three months.99%Medication Management If started new meds, discussed risk vs. benefit of therapy97%Currently prescribed any antimalarial therapy92%Attempted to taper a dose of steroids not acceptable for chronic use.89%Attempted to taper and unable to decrease steroid; added/increased steroid sparing agent.41%Surveillance for medication safety done at regular intervals.99%Bone Health Received at least one bone mineral density testing DEXA scan72%Repeat bone mineral density testing if baseline testing outside normal limits (Z score ≤2)62%Prescribed calcium/vitamin D if a patient is on any steroid therapy.78%Ophthalmological surveillance Receives eye exams annually while on anti-malarial therapy82%Receives eye exams annually while on glucocorticoids85%Education on cardiovascular risk factors Education on cardiovascular risk factors (smoking, hypertension, high BMI) every 1 year with patient and parent if patient is 13 years or older.86%Discussed lifestyle modifications (smoking cessation, weight control, exercise) every 2 years with parent and patient 13 years or older.87%Pregnancy Anti-SSA, anti-SB and anti-phospholipid antibodies have been assessed during pregnancy100%CNS health Prescribed Immunosuppressive therapy if patient has major neuropsychiatric manifestations in last year of care (Optic neuritis, coma, psychosis … etc.)94%Conclusion:Based on this initial benchmarking effort, the medical care of patients with cSLE at tertiary pediatric rheumatology centers is very good. Systematic planning and documentation of patient education on lifestyle modifications seems warranted and is expected to improve the self-management skills of cSLE patients. Furthermore, increased focus on bone health, eye exams annually, and adequate vaccination of cSLE patients are areas to continue to monitor." @default.
• W2006588788 created "2016-06-24" @default.
• W2006588788 creator A5000164393 @default.
• W2006588788 creator A5015977988 @default.
• W2006588788 creator A5018365369 @default.
• W2006588788 creator A5033102003 @default.
• W2006588788 creator A5037646848 @default.
• W2006588788 creator A5042867042 @default.
• W2006588788 creator A5043834225 @default.
• W2006588788 creator A5054768749 @default.
• W2006588788 creator A5062989028 @default.
• W2006588788 creator A5077003614 @default.
• W2006588788 creator A5079354971 @default.
• W2006588788 creator A5088481433 @default.
• W2006588788 date "2014-03-01" @default.
• W2006588788 modified "2023-10-01" @default.
• W2006588788 title "A133: Initial Benchmarking of the Quality of Medical Care of Children and Adolescents with Lupus" @default.
• W2006588788 doi "https://doi.org/10.1002/art.38554" @default.
• W2006588788 hasPublicationYear "2014" @default.
• W2006588788 type Work @default.
• W2006588788 sameAs 2006588788 @default.
• W2006588788 citedByCount "0" @default.
• W2006588788 crossrefType "journal-article" @default.
• W2006588788 hasAuthorship W2006588788A5000164393 @default.
• W2006588788 hasAuthorship W2006588788A5015977988 @default.
• W2006588788 hasAuthorship W2006588788A5018365369 @default.
• W2006588788 hasAuthorship W2006588788A5033102003 @default.
• W2006588788 hasAuthorship W2006588788A5037646848 @default.
• W2006588788 hasAuthorship W2006588788A5042867042 @default.
• W2006588788 hasAuthorship W2006588788A5043834225 @default.
• W2006588788 hasAuthorship W2006588788A5054768749 @default.
• W2006588788 hasAuthorship W2006588788A5062989028 @default.
• W2006588788 hasAuthorship W2006588788A5077003614 @default.
• W2006588788 hasAuthorship W2006588788A5079354971 @default.
• W2006588788 hasAuthorship W2006588788A5088481433 @default.
• W2006588788 hasConcept C111472728 @default.
• W2006588788 hasConcept C126322002 @default.
• W2006588788 hasConcept C138885662 @default.
• W2006588788 hasConcept C144133560 @default.
• W2006588788 hasConcept C162853370 @default.
• W2006588788 hasConcept C2776912625 @default.
• W2006588788 hasConcept C2779134260 @default.
• W2006588788 hasConcept C2779530757 @default.
• W2006588788 hasConcept C512399662 @default.
• W2006588788 hasConcept C71924100 @default.
• W2006588788 hasConcept C86251818 @default.
• W2006588788 hasConceptScore W2006588788C111472728 @default.
• W2006588788 hasConceptScore W2006588788C126322002 @default.
• W2006588788 hasConceptScore W2006588788C138885662 @default.
• W2006588788 hasConceptScore W2006588788C144133560 @default.
• W2006588788 hasConceptScore W2006588788C162853370 @default.
• W2006588788 hasConceptScore W2006588788C2776912625 @default.
• W2006588788 hasConceptScore W2006588788C2779134260 @default.
• W2006588788 hasConceptScore W2006588788C2779530757 @default.
• W2006588788 hasConceptScore W2006588788C512399662 @default.
• W2006588788 hasConceptScore W2006588788C71924100 @default.
• W2006588788 hasConceptScore W2006588788C86251818 @default.
• W2006588788 hasLocation W20065887881 @default.
• W2006588788 hasOpenAccess W2006588788 @default.
• W2006588788 hasPrimaryLocation W20065887881 @default.
• W2006588788 hasRelatedWork W1549703553 @default.
• W2006588788 hasRelatedWork W1560243578 @default.
• W2006588788 hasRelatedWork W1723627410 @default.
• W2006588788 hasRelatedWork W1768995123 @default.
• W2006588788 hasRelatedWork W1979592296 @default.
• W2006588788 hasRelatedWork W1981752809 @default.
• W2006588788 hasRelatedWork W2005282772 @default.
• W2006588788 hasRelatedWork W2061998463 @default.
• W2006588788 hasRelatedWork W2105513358 @default.
• W2006588788 hasRelatedWork W2595337772 @default.
• W2006588788 hasVolume "66" @default.
• W2006588788 isParatext "false" @default.
• W2006588788 isRetracted "false" @default.
• W2006588788 magId "2006588788" @default.
• W2006588788 workType "article" @default.